Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial - Reuter, Uwe; Lucas, Christian; Dolezil, David; Hand, Austin L.; Port, Martha D.; Nichols, Russell M.; Stroud, Chad; Tockhorn-Heidenreich, Antje; Detke, Holland C. (Advances in therapy, 2021)
Keywords: Adolescent; Adult; Aged; Antibodies, Monoclonal - therapeutic use; Antibodies, Monoclonal, Humanized; Cardiology; Endocrinology; Humans; Internal Medicine; Medicine; Medicine & Public Health; Middle Aged; Migraine Disorders - drug therapy; Migraine Disorders - prevention & control; NCT; NCT03559257; Oncology; Original Research; Pharmacology/Toxicology; Rheumatology; Treatment Outcome; Young Adult; Chronic migraine; Episodic migraine; Treatment failure; Galcanezumab; Monoclonal antibody; CGRP; Elderly; Migraine preventive